Biomarkers in hepatocellular carcinoma: current status and future perspectives
Hepatocellular carcinoma (HCC) is the most common primary liver cancer and one of the
leading causes of cancer-related death worldwide. HCC is highly heterogeneous, both …
leading causes of cancer-related death worldwide. HCC is highly heterogeneous, both …
Protein glycosylation in gastric and colorectal cancers: Toward cancer detection and targeted therapeutics
JA Ferreira, A Magalhaes, J Gomes, A Peixoto… - Cancer letters, 2017 - Elsevier
Glycosylation is the most frequent and structurally complex posttranslational modification in
cell-surface and secreted proteins. Glycans are major orchestrators of biological processes …
cell-surface and secreted proteins. Glycans are major orchestrators of biological processes …
Hepatocellular carcinoma: nomograms based on the albumin-bilirubin grade to assess the outcomes of radiofrequency ablation
Purpose To construct a nomogram with the albumin-bilirubin (ALBI) grade to assess the long-
term outcomes of patients with early-stage hepatocellular carcinoma (HCC) after …
term outcomes of patients with early-stage hepatocellular carcinoma (HCC) after …
[HTML][HTML] Postoperative adjuvant transarterial chemoembolization for multinodular hepatocellular carcinoma within the Barcelona Clinic Liver Cancer early stage and …
H Wang, PC Du, MC Wu, WM Cong - Hepatobiliary surgery and …, 2018 - ncbi.nlm.nih.gov
Background The survival benefit of postoperative adjuvant transcatheter arterial
chemoembolization (PA-TACE) remained controversial. We aimed to investigate the …
chemoembolization (PA-TACE) remained controversial. We aimed to investigate the …
The current landscape of therapies for hepatocellular carcinoma
K Coffman-D'Annibale, C **e, DM Hrones… - …, 2023 - academic.oup.com
Globally, primary liver cancer is the third leading cause of cancer-related deaths, with
approximately 830 000 deaths worldwide in 2020, accounting for 8.3% of total deaths from …
approximately 830 000 deaths worldwide in 2020, accounting for 8.3% of total deaths from …
Medical applications of Cu, Zn, and S isotope effects
This review examines recent applications of stable copper, zinc and sulfur isotopes to
medical cases and notably cancer. The distribution of the natural stable isotopes of a …
medical cases and notably cancer. The distribution of the natural stable isotopes of a …
[HTML][HTML] Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society …
Background Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related
mortality in Taiwan. To help clinical physicians to manage patients with HCC, the Taiwan …
mortality in Taiwan. To help clinical physicians to manage patients with HCC, the Taiwan …
Efficacy and safety profile of drug-eluting beads transarterial chemoembolization by CalliSpheres® beads in Chinese hepatocellular carcinoma patients
GH Zhou, J Han, JH Sun, YL Zhang, TY Zhou, CH Nie… - BMC cancer, 2018 - Springer
Background This study aimed to investigate the efficacy and safety of drug eluting beads
transarterial chemoembolization (DEB-TACE) treatment by CalliSpheres® in Chinese …
transarterial chemoembolization (DEB-TACE) treatment by CalliSpheres® in Chinese …
Medical applications of isotope metallomics
One may wonder how a paper discussing medical applications of metal isotopes got lost in a
review journal dedicated to mineralogy and geochemistry. The justifications are multiple …
review journal dedicated to mineralogy and geochemistry. The justifications are multiple …
Combination of albumin-bilirubin grade and platelets to predict a compensated patient with hepatocellular carcinoma who does not require endoscopic screening for …
Backgrounds and Aims There is no consensus on screening for high-risk esophageal
varices (HRV) in patients with hepatocellular carcinoma (HCC). Here, we aimed to …
varices (HRV) in patients with hepatocellular carcinoma (HCC). Here, we aimed to …